SCHEMBL29551896

SCHEMBL29551896

CCOc1ccc(Nc2cc(Cl)nnc2C(=O)O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EHMT2 Q96KQ7 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ ALDH1A1 P00352 4/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ GAA P10253 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ NFKB1 P19838 1/20 0.46
▸ SYK P43405 1/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ MAPT P10636 6/20 0.44
▸ LMNA P02545 3/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ EGFR P00533 1/20 0.44
▸ ERBB3 P21860 1/20 0.44
▸ NPC1 O15118 4/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.43
▸ HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28359257 0.89 ALDH1A1 (0.47) EHMT2POLBALDH1A1KDM4ENFKB1
SCHEMBL29922643 0.89 ALDH1A1 (0.47) EHMT2POLBALDH1A1KDM4ENFKB1
SCHEMBL29552492 0.79 SYK (0.46) POLBNFKB1SYKMAPTLMNA
SCHEMBL28362708 0.78 DHODH (0.45) POLBALDH1A1KDM4EGAAALOX15
SCHEMBL29552431 0.78 SYK (0.48) POLBALDH1A1GAANFKB1SYK
SCHEMBL23486571 0.77 ILK (0.56) ALDH1A1GAAALOX15SYKSMN1; SMN2
SCHEMBL29552807 0.75 SYK (0.41) ALDH1A1SYKMAPTLMNAKMT2A
SCHEMBL22609234 0.75 ALDH1A1 (0.49) POLBALDH1A1KDM4EGAASYK
SCHEMBL29552337 0.75 SYK (0.40) POLBALDH1A1SYKMAPTLMNA
SCHEMBL29551786 0.74 SYK (0.44) POLBALDH1A1SYKKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022032484-A1 PYRIDAZINE-3-FORMAMIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 北京诺诚健华医药科技有限公司 2022-02-17 — — WO disclosed
Send feedback